Tassone, Flora

Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome

Greco, C. M., Navarro, C. S., Hunsaker, M. R., Maezawa, I., Shuler, J. F., Tassone, F., Delany, M., Au, J. W., Berman, R. F., Jin, L.-W., et al. (2011) · Molecular Autism

Genetics and Neurodevelopmental DisordersGenetic Neurodegenerative Diseases

Cited by 90

Plasma cytokine profiles in Fragile X subjects: Is there a role for cytokines in the pathogenesis?

Ashwood, P., Nguyen, D. V., Hessl, D., Hagerman, R. J., & Tassone, F. (2010) · Brain, Behavior, and Immunity

Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research

Cited by 80

Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder

García‐Nonell, C., Ratera, E. R., Harris, S., Hessl, D., Ono, M. Y., Tartaglia, N., Marvin, E., Tassone, F., & Hagerman, R. J. (2008) · American Journal of Medical Genetics Part A

Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research

Cited by 76

Metformin treatment in young children with fragile X syndrome

Biag, H. M. B., Potter, L. A., Wilkins, V., Afzal, S., Rosvall, A., Salcedo‐Arellano, M. J., Rajaratnam, A., Manzano‐Nunez, R., Schneider, A., Tassone, F., et al. (2019) · Molecular Genetics & Genomic Medicine

Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research

Cited by 68

Selected vitamin D metabolic gene variants and risk for Autism Spectrum Disorder in the charge study

Schmidt, R. J., Hansen, R. L., Hartiala, J., Allayee, H., Sconberg, J. L., Schmidt, L. C., Volk, H. E., & Tassone, F. (2015) · Early Human Development

Autism Spectrum Disorder ResearchVitamin D Research Studies

Cited by 68

Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome

Thurman, A. J., Potter, L. A., Kim, K., Tassone, F., Banasik, A., Potter, S. N., Bullard, L., Nguyen, V., McDuffie, A., Hagerman, R., et al. (2020) · Journal of Neurodevelopmental Disorders

Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research

Cited by 58

A randomized controlled trial of sertraline in young children with autism spectrum disorder

Potter, L. A., Scholze, D. A., Biag, H. M. B., Schneider, A., Chen, Y., Nguyen, D. V., Rajaratnam, A., Rivera, S. M., Dwyer, P. S., Tassone, F., et al. (2019) · Frontiers in Psychiatry

Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental Disorders

Cited by 43

Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin‐two cases

Protic, D., Aydin, E. Y., Tassone, F., Tan, M. M., Hagerman, R. J., & Schneider, A. (2019) · Molecular Genetics & Genomic Medicine

Genetics and Neurodevelopmental DisordersDown syndrome and intellectual disability research

Cited by 34

Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome

Careaga, M., Noyon, T., Basuta, K., Van de Water, J., Tassone, F., Hagerman, R. J., & Ashwood, P. (2014) · Journal of Neuroinflammation

Genetics and Neurodevelopmental DisordersImmunodeficiency and Autoimmune Disorders

Cited by 20

Hypermobile Ehlers-Danlos syndrome (hEDS) phenotype in fragile X premutation carriers: case series

Tassanakijpanich, N., McKenzie, F. J., McLennan, Y. A., Makhoul, E., Tassone, F., Jasoliya, M. J., Romney, C., Petrasic, I. C., Napalinga, K., Buchanan, C. B., et al. (2022) · Journal of Medical Genetics

Genetics and Neurodevelopmental DisordersConnective tissue disorders research

Cited by 9

In utero alcohol and unsuitable home environmental exposure combined with FMR1 full mutation allele cause severe fragile X syndrome phenotypes

Winarni, T. I., Aishworiya, R., Culpepper, H., Zafarullah, M., Mendoza, G., Wilaisakditipakorn, T. J., Likhitweerawong, N., Law, J., Hagerman, R., & Tassone, F. (2025) · International Journal of Molecular Sciences

Genetics and Neurodevelopmental DisordersPrenatal Substance Exposure Effects

Cited by 3